Delivery Order SPE2DB20D1109-SPE2DB24FN33X
Award Date 12/28/23
Potential Completion Date 12/29/23
Potential Value $7.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml pen 2 ml pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $12,109.75 and is a firm fixed-price delivery order with a completion date of November 8, 2023. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml pen 2 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $5,242.91 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a completion date of February 29, 2024 and was awarded on February 28, 2024. This appears to be part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml pen, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $13,429.74 and an ultimate completion date of December 18, 2023. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that is a subsidiary of Cencora, Inc. This contract is a delivery order and is priced on a firm fixed-price basis. There is no set-aside...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml pen, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,652.35 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 17, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award is a delivery order with a ceiling value of $31,377.75 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dupixent 300 mg/2 ml pen, a pharmaceutical product, with a performance period extending through May 28, 2025. The contract is designated as a firm fixed-price arrangement and does not have a set-aside designation, indicating open...
- This federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Dupixent 300 mg/2 ml pens. The contract, awarded by the Defense Logistics Agency (DLA), has a ceiling value of $6,665.02 and an ultimate completion date of May 18, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a...
- This federal contract award is for the delivery of the pharmaceutical product Dupixent 300 mg/2 ml pen, with a ceiling value of $1,652.35. The award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 8, 2024 and is structured as a firm fixed-price delivery order. The contract is not designated as a set-aside....
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml pen, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The $13,717.44 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 16, 2025 with a completion date of July 17, 2025. This is a delivery order contract that is not set aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml pens. The $25,339.82 firm-fixed-price contract has an ultimate completion date of August 19, 2022. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml pens to the Defense Logistics Agency (DLA). The contract, valued at $9,737.94, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of March 8, 2024 and is a firm fixed-price delivery order. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent...